Catalyst

Slingshot members are tracking this event:

Janssen's (JNJ) Stelara Recommended for Approval by European Ad Comm for Treatment of Crohn's Disease

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
JNJ

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 16, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Stelara, Chrons Disease, Moderately To Severely Active, European Medicines Agency, Chmp